Patient Participation in Prevention of Loss of Functions
Cross-sectorial Patient Participation in Prevention of Loss of Functions in Older Short-stay Medical Patients
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
At baseline:
Nutritional status, BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test), quality of life (EQ5D), coping (Sense of Coherence 13 item scale), patient experience (NORPEQ), medication management (MedMaide).
At follow-up three months after discharge:
BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test) and EQ5D. In addition, need for initiated municipal assistance after discharge. Project employee who performs data collection is blinded to the group to which the patient is randomized.
The control group Patients in the control group undergo the same measurements and registrations at discharge and 3 - month follow-up, as the intervention groups, but receive otherwise usual treatment and care, and are discharged without further intervention. After six months control patients receive a report comprising the screening results, relevant information material and a cover letter. Patients' GP and municipality care section receive a summary of outcomes, as well as a cover letter.
Register data Information on mortality, readmissions and services in primary health care are obtained after 6 months from the National Patient Register, Population Register and municipalities.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Herlev, Danemark, 2730
- Herlev Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- 65 years or older
- Living in their own home with no contact to the Municipality, both before and after admission
- Discharged from Department o105 or the Acute Receiving Unit <48 hours from admission.
Exclusion Criteria:
- Patients with life-threatening disease in the terminal stage
- Patients who does not speak and understand Danish
- Patients who are not able to communicate and collaborate, with regards to the measurements
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Autre: Empowerment
Patients in the intervention group 1 receive a communication report which will also be sent to the physician and home care.
In communication report includes the results and interpretation and explanation of the measurements in layman's terms.
The report also includes relevant and targeted information on pain management, depression among the elderly, dementia and disability in old age and ways to maintain and improve functional capacity.
Links and addresses of relevant, local organizations, and networks are also included.
The information material is also included in the report sent to the General Practitioner (GP) and home care.
|
To give patients the necessary resources to take care of their own health
|
|
Autre: Conversation with Nurse
Patients in the intervention group 2 gets clarification and follow-up conversation with a nurse anchored in both medical department and municipalities.
The nurse is "blinded" in relation to the patient's screening results.
Problems identified in connection therewith are communicated to the GP and home care.
|
To find out, if the nurse, using her ....
|
|
Aucune intervention: Controle Group
Patients in the control group are undergoing the same measurements and records at discharge, as the intervention group, but are otherwise receiving treatment and care as usual without further intervention.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of participants who have been readmitted to hospital
Délai: 01.03.2013 - 12.31.2014
|
Number of participants who have been readmitted to hospital.
Measured 6 months after admission.
|
01.03.2013 - 12.31.2014
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Mortality
Délai: 01.04.2014 - 31.12.2014
|
Mortality.
Number of participants, who have died.
Measured 6 months after admission.
|
01.04.2014 - 31.12.2014
|
|
Functional ability
Délai: 31.12.2014
|
Measured 3 months after discharge. Functional ability Handgrip-strength 4 second test: Hand- and forearm muscular strength in kg. and 30 second chair stand test: Lower-body muscle strength |
31.12.2014
|
|
Primary Healthcare Services
Délai: 01.04.2013 - 31.12.2014
|
Delivered services in Primary Healthcare.
Measured 6 months after admission.
|
01.04.2013 - 31.12.2014
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Tove L. Damsgaard, Herlev Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- H-1-2012-118
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .